| View Larger Image | Non-Small Cell Lung Cancer: New Therapies (Home Use) | DVD-R
| List Price: | $24.95 | | | Available: | Usually ships in 24 hours |
| | Binding: | DVD-R | | Studio: | Information Television Network | | Number of Discs: | | | Release Date: | April 05, 2007 | | Sales Rank: | 160,829th |
|
EDITORIAL REVIEWS |
Description
Lung cancer is the leading cancer killer among men and women alike, claiming more lives than breast, colon and prostate cancer combined. Non-small cell lung cancer is the most common type of this disease, accounting for 87 percent of all lung cancers. Because lung cancer has usually spread throughout the body before it is discovered, the survival rates for patients are quite poor. But new therapies and advances in imaging studies that could lead to earlier detection are serving as beacons of hope for patients and their families. This program is part of the award winning public television series Healthy Body, Healthy Mind.This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
SIMILAR PRODUCTS |
| Winning the Battle Against Prostate Cancer (Home Use)
Thanks to a blood test called prostate specific antigen, or PSA, the quest to discover prostate cancer early is made easier. As a result of early detection, over eighty percent of patients with prostate cancer can be cured. Researchers now believe that prostate cancer cells grow in part due to a failure of the body's immune system to recognize and react to these cells. In this program we explore the new ways to help the immune system recognize prostate cancer cells, and hopefully destroy them. ...
| 
| Targeted Cancer Therapy (Home Use)
Part of the award winning public television series Healthy Body/Healthy Mind. For dozens of years, the most common forms of cancer treatments included traditional chemotherapy, radiation and possibly surgery. Now newer medications are emerging, thanks to advances in science. Research has brought about a better understanding of cancer on a molecular level. This understanding is resulting in medicines that zero in on properties unique to cancer cells, allowing those medicines to selectively...
|
|
|
